Akt

Cat.No. Product Name Feedback Added

S2670

A-674563

Aug 2011
A-674563 is a potent selective protein kinase B/Akt inhibitor with an IC50 of 14 nM.
S1558

AT7867

Nov 2010
AT7867 is a potent and oral AKT and p70 S6 kinase inhibitor with an IC50 of 17 nM.
S2635

CCT128930

Jul 2011
CCT128930 is a novel potent ATP-competitive, AKT inhibitor with an IC50 of 6 nM.
S1113

GSK690693

Sep 2009
pan-Akt kinase inhibitor,IC50 of Akt 1, 2, and 3 at 2, 13, and 9 nM respectively.
S1078

MK-2206

Jun 2009
MK-2206 is a highly selective, potent non-ATP competitive allosteric Akt inhibitor with IC50 of 5.3 nM,12 nM, 65 nM for Akt1, Akt2 and Akt3 respectively.
S2238

Palomid 529 (P529)

May 2011
Palomid 529 (P529) is a novel potent antitumour PI3K/Akt/mTOR inhibitor with a GI50 of <35 μM in the NCI-60 cell lines panel.
S1037

Perifosine

Apr 2009
Perifosine is a novel Akt and PI3K inhibitor with IC50 of median 4.7 µM.
S1556

PHT-427

Nov 2010
PHT-427 is a Novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor with an IC50 of 6.3 μM for AKT inhibition in Panc-1 cells.
S1117

Triciribine

Sep 2009
Triciribine is a synthetic tricyclic nucleoside which acts as a specific inhibitor of the Akt signaling pathway.
S2732

Triciribine phosphate (NSC-280594) 

Nov 2011
Triciribine phosphate (NSC-280594) is a novel potent, small-molecule Akt inhibitor.
Buy Now / Print Quote

Find Multiple Products by Catalog Number

Continue
Customer's Feedback
Arnaud AUTRET, Trinity College
"I would like to confirm you that everything is perfectly fine with ABT and Obatoclax we got from your company. We confirmed their activity in vitro. We notably observed their impact in an apoptotic model and results are similar to those which have been published."

Dongfeng Chen, The Rausing Lab
"Your product U0126(Cat.NO S1102) works well in our experiments. I hope I can get more excellent products from your company in future."

Dr. Alexandra Segref, CECAD Cologne,Germay
"I am very satisfied with your product and costumer service. Bortezomib works very well in our assay, it is comparably cheaper than other inhibitors that we tested is more reliable for our assays. We see a great effect by using 10nM concentration."

R.B. Cambridge
"I have used the chemical that I bought from you(Selleck,PTC-124) and it worked well.So we will eventually be ordering more."

Zhenghe John Wang Assistant Professor, Case Western Reserve University
"We have purchased LBH-589, Saha and MS-275 from you and they all worked well."

Jenny Sun
"We used the LBH-589 in our experiments. The compound is easy to use with excellent reproducibility."

Yu Wang, Harvard University
"The GDC0449 compound worked very well. The results in my hands are equally good as what's been published. Thanks for this great resource for our research."

Philip Seeman, Toronto University
"Your LY404039 compound was well synthesized, its complicated stereochemical structure confirmed by NMR spectroscopy, and was biologically excellent in acting on brain dopamine receptors."

Dung-Fang Lee
"Based on our preliminary data, I found MLN8237 and VX-680 have good effects in inhibiting Aurka-maintaining ESC self-renewal in mouse ES cells."

Latest Catalog
May 2010
Selleck
Latest
Catalog

Selleck Chemicals Catalog
| Inhibitor | Antibody | siRNA | Protein | Peptide | Cell Signal | © Copyright 2010 Selleck. All Rights Reserved.